特定于光滑肌肉细胞的CD47删除抑制了动脉样硬化
Naveed Pervaiz1, Rashid Mehmood2, Ravi Varma Aithabathula1
1Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA.
Life sciences
|December 15, 2024
概括
向由血栓蛋白-1 (TSP1) 激活的光滑肌肉 (SMC) 细胞CD47,通过调节VSMC表型来抑制动脉样硬化发展. 在SMC中删除CD47可以减少动脉样硬化病变并改善血细胞分裂.
科学领域:
- 血管生物学 血管生物学
- 免疫学 免疫学 免疫学
- 细胞和分子医学 细胞和分子医学
背景情况:
- 平滑肌细胞 (SMC) 衍生细胞在动脉样硬化中起着关键作用.
- 血栓蛋白-1 (TSP1) 和它的受体分化集群 (CD) 47都与动脉样硬化有关.
- 血管SMCTSP1-CD47信号在VSMC表型和动脉生成中的特定作用尚不清楚.
研究的目的:
- 调查TSP1对SMC CD47激活在调节VSMC表型中的作用.
- 确定SMC TSP1-CD47信号对动脉样硬化发展的影响.
主要方法:
- 在体外基于细胞的测定和分子生物学技术.
- 免疫组织学,scRNA-seq数据再分析,以及细胞特异性淘汰赛小鼠.
- 研究了TSP1-CD47相互作用及其对VSMC标志物和扩散的影响.
主要成果:
- TSP1增加了VSMC增殖和减少了收缩标记物;CD47调解了这些效应.
- 在小鼠中,SMC特异性的Cd47缺失抑制了动脉样硬化,减少了死细胞区域,并减少了巨细胞积累.
- 人类VSMC中的CD47敲击逆转了TSP1诱导的变化,并增强了apoptoticVSMC的效细胞化.
结论:
- CD47是VSMC表型的关键调节者.
- 向SMC CD47信号是一种有前途的治疗策略,可以抑制动脉样硬化.
- 特定于VSMC的Cd47缺失通过调节VSMC表型和改善细胞化来减轻动脉样硬化.
相关概念视频
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...